Mylan (MYL)

Mylan Laboratories said today it had a third-quarter net loss attributable to Mylan common shareholders of $40.02 million or $0.13 per share, compared to profit of $182.36 million or $0.47 per share in the same quarter last year. Total revenues for the quarter declined to $1.264 billion from $1.656 billion in the prior year quarter. .
Analysts had a consensus revenue estimate of $1.23 billion in revenue for the quarter.

Oct 29 · 9:33:00 AM · Source: Company News
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter